Tech Company Financing Transactions

Cambrian Biopharma Funding Round

Cambrian Biopharma closed a $100 million Series C venture capital round on 10/27/2021. Investors included Anthos Capital, Salt Funds Management and Apeiron Investment Group.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

228 Park Ave. South 66643
New York, NY 10003
USA

Phone

Undisclosed

Website

www.cambrianbio.com

Email Address

[email protected]

Overview

A true partner in the pursuit of expanded healthspan. Cambrian's scientists and company-building experts closely partner with research teams, offering scientific and organizational insights and support for a significant edge in a complex, rapidly evolving field.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

James Peyer

        

Chief Operating Officer

Juliette Han

        

Executive Vice President

Georg Terstappen

        

Executive Vice President

Dennis Yamashita

        

VP - Bus. Development

Mark Nuttall

        

VP - General Counsel

Teri Champ

        

Browse more venture capital transactions:

Prev: 10/27/2021: Admix venture capital transaction
Next: 10/27/2021: BackBox Software venture capital transaction

Share this article

About Database of VC Transactions

Our team works diligently to report on every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary